Discovery of an Orally Available, Brain Penetrant BACE1 Inhibitor That Affords Robust CNS Aβ Reduction

[Image: see text] Inhibition of BACE1 to prevent brain Aβ peptide formation is a potential disease-modifying approach to the treatment of Alzheimer’s disease. Despite over a decade of drug discovery efforts, the identification of brain-penetrant BACE1 inhibitors that substantially lower CNS Aβ level...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Stamford, Andrew W., Scott, Jack D., Li, Sarah W., Babu, Suresh, Tadesse, Dawit, Hunter, Rachael, Wu, Yusheng, Misiaszek, Jeffrey, Cumming, Jared N., Gilbert, Eric J., Huang, Chunli, McKittrick, Brian A., Hong, Liwu, Guo, Tao, Zhu, Zhaoning, Strickland, Corey, Orth, Peter, Voigt, Johannes H., Kennedy, Matthew E., Chen, Xia, Kuvelkar, Reshma, Hodgson, Robert, Hyde, Lynn A., Cox, Kathleen, Favreau, Leonard, Parker, Eric M., Greenlee, William J.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Chemical Society 2012
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3568987/
https://ncbi.nlm.nih.gov/pubmed/23412139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml3001165
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items